According to the proteomic data, PKM2 was indeed highly expressed in thyroid cancer (Figure 7(b)), and the differentially expressed proteins were mainly enriched in the following pathways: ribosome, apoptosis, and glutathione metabolism (Figure 7(c)). The gene discussed is PKM; the disease is thyroid cancer.